Heidi Lyng

7PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 27, 2024
Spatial analysis of microRNA regulation at defined tumor hypoxia levels reveals biological traits of aggressive prostate cancer.

Vilde E Skingen, Unn Beate Salberg, Tord Hompland

|Jan 05, 2024
An Immune Gene Expression Risk Score for Distant Metastases after Radiotherapy for Cervical Cancer.

Jelena Lukovic, Melania Pintilie, Kathy Han

|Oct 14, 2022
Targeted Therapy on the Screen: Do We Hit the Target?

Heidi Lyng, Kjersti Skipar, Tord Hompland

|Oct 07, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.

Ankur Chakravarthy, Ian Reddin, Stephen Henderson

|Mar 25, 2022
A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients.

Unn Beate Salberg, Vilde Eide Skingen, Christina Sæten Fjeldbo

|Jan 22, 2022
miR-200a/b/-429 downregulation is a candidate biomarker of tumor radioresistance and independent of hypoxia in locally advanced cervical cancer.

Anja Nilsen, Tiril Hillestad, Vilde E Skingen

Pageof 2

Frequent Collaborators

2 joint publications

Vilde Eide Skingen

1 joint publications

Beata Grallert

1 joint publications

Ian Reddin

1 joint publications

Stephen Henderson